• 中药标准品生产商,产品定制服务
  • Science | Nature | Cell | View More

    氧化苦参碱; 苦参素


    氧化苦参碱; 苦参素
    产品编号 CFN99805
    CAS编号 16837-52-8
    分子式 = 分子量 C15H24N2O2 = 264.4
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Alkaloids
    植物来源 The roots of Sophora flavescens Ait
    产品名称 产品编号 CAS编号 包装 QQ客服
    氧化苦参碱; 苦参素 CFN99805 16837-52-8 10mg QQ客服:1413575084
    氧化苦参碱; 苦参素 CFN99805 16837-52-8 20mg QQ客服:1413575084
    氧化苦参碱; 苦参素 CFN99805 16837-52-8 50mg QQ客服:1413575084
    氧化苦参碱; 苦参素 CFN99805 16837-52-8 100mg QQ客服:1413575084
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.

    PMID: 30417089
  • National Cancer Institute (USA)
  • Aarhus University (Denmark)
  • University of Auckland (New Zealand)
  • National Cancer Center Research Institute (Japan)
  • Aveiro University (Portugal)
  • Center for protein Engineering (CIP) (Belgium)
  • Agricultural Research Organization (ARO) (Israel)
  • Nicolaus Copernicus Uniwersity (Poland)
  • Pennsylvania State University (USA)
  • Calcutta University (India)
  • Institute of Bioorganic Chemistry Polish Academy of Sciences (Poland)
  • Wageningen University (Netherlands)
  • University of Illinois at Chicago (USA)
  • Research Unit Molecular Epigenetics (MEG) (Germany)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Anticancer Res.2014, 34(7):3505-9
  • Mol Med Rep.2014, 9(5):1653-9
  • Nat Prod Commun.2014, 9(5):679-82
  • Appl Microbiol Biotechnol.2016, 100(9):3965-77
  • Nat Prod Sci.2016, 22(2)
  • Chem Biol Interact.2016, 258:59-68
  • Evid Based Complement Alternat Med.2017, 2017:1583185
  • Mol Cell.2017, 68(4):673-685
  • Sci Rep.2017, 7:46299
  • Oncotarget.2017, 8(53):90925-90947
  • Oncotarget.2017, 9(3):4161-4172
  • Int J Biol Macromol.2018, 112:1093-1103
  • Neurochem Int.2018, 121:114-124
  • Malaysian J of Fundamental and Applied Sciences 2018, 14(3):368-373
  • J Ethnopharmacol.2018, 210:88-94
  • J Cell Mol Med.2018, 22(9):4236-4242
  • Korean J of Medicinal Crop Science2018, 220-226
  • Chem Biol Interact.2018, 290:44-51
  • Biochemical Systematics and Ecology2018, 81
  • Journal of Life Science2018, 917-922
  • Molecules.2019, 24(22):E4022
  • Planta Med.2019, 85(3):217-224
  • Plos One.2020, 10.1371
  • ...
  • 生物活性
    Description: Oxymatrine has exhibited anti-hepatitis virus infection, anti-hepatic fibrosis, anti-inflammation, anti-anaphylaxis and other immune-regulation, it induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome C. It can attenuate diabetes-associated cognitive deficits in rats, which is associated with oxidative stress, inflammation and apoptotic cascades, it is proven to protect ischemic and reperfusion injury in liver, intestine and heart.
    Targets: Bcl-2/Bax | Caspase | IAP | NF-kB | IL Receptor | TNF-α | p38MAPK | p65 | Wnt/β-catenin
    In vitro:
    J Exp Clin Cancer Res. 2011; 30(1): 66.
    Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c[Pubmed: 21714853]
    Oxymatrine, an isolated extract from traditional Chinese herb Sophora Flavescens Ait, has been traditionally used for therapy of anti-hepatitis B virus, anti-inflammation and anti-anaphylaxis. The present study was to investigate the anti-cancer effect of oxymatrine on human pancreatic cancer PANC-1 cells, and its possible molecular mechanism.
    The effect of oxymatrine on the viability and apoptosis was examined by methyl thiazolyl tetrazolium and flow cytometry analysis. The expression of Bax, Bcl-2, Bcl-x (L/S), Bid, Bad, HIAP-1, HIAP-2, XIAP, NAIP, Livin and Survivin genes was accessed by RT-PCR. The levels of cytochrome c and caspase 3 protein were assessed by Western blotting. Oxymatrine inhibited cell viability and induced apoptosis of PANC-1 cells in a time- and dose-dependent manner. This was accompanied by down-regulated expression of Livin and Survivin genes while the Bax/Bcl-2 ratio was upregulated. Furthermore, oxymatrine treatment led to the release of cytochrome c and activation of caspase-3 proteins.
    Oxymatrine can induce apoptotic cell death of human pancreatic cancer, which might be attributed to the regulation of Bcl-2 and IAP families, release of mitochondrial cytochrome c and activation of caspase-3.
    Med Oncol. 2011 Dec;28 Suppl 1:S99-107.
    Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells.[Pubmed: 21069479 ]
    Cancer stem cells (CSCs) play a critical role in both cancer initiation and relapse as they are resistant to most cytotoxic agents and able to proliferate indefinitely. The plant alkaloid oxymatrine has many biological activities including the ability to induce cell cycle arrest and apoptosis, which makes it a potentially useful agent for targeting cancer cells.
    In order to determine whether it has beneficial pharmacological properties to eradicate CSCs, we analyzed the effects of oxymatrine on MCF-7 breast cancer cells. Cancer stem-like cells' (side population, SP) identification and sorting were performed. The inhibitory effect of oxymatrine was evaluated on the sorted SP and non-SP cells. The results indicated that oxymatrine caused a dose-dependent reduction in the proliferation of MCF-7 cells and a decrease in SP cells.
    Wnt/β-catenin signaling pathway was also examined by analyzing the expression of total β-catenin and phosphorylated β-catenin in cytoplasm, and the results showed that the growth inhibitory effects of oxymatrine treatment on MCF-7 cells may be due to the inhibition of SP and Wnt/β-catenin signaling pathway. Further work is warranted to explore whether oxymatrine may be a useful novel therapeutic drug for targeting breast CSCs.
    In vivo:
    Brain Res. 2009 May 1;1268:174-80.
    Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression.[Pubmed: 19285049 ]

    Male, Sprague-Dawley rats were randomly assigned to four groups: permanent middle cerebral artery occlusion (pMCAO), high dose (pMCAO+oxymatrine 120 mg/kg), low dose (pMCAO+oxymatrine 60 mg/kg) and sham operated group. We used a permanent middle cerebral artery occlusion model and administered oxymatrine intraperitoneally immediately after cerebral ischemia and once daily on the following days. At 24 h after MCAO, neurological deficit was evaluated using a modified six point scale; brain water content was measured; NF-kappaB expression was measured by immunohistochemistry, Western blotting and RT-PCR. Infarct volume was analyzed with 2, 3, 5-triphenyltetrazolium chloride (TTC) staining at 72 h. Compared with pMCAO group, neurological deficit in high dose group was improved (P<0.05), infarct volume was decreased (P<0.001) and cerebral edema was alleviated (P<0.05). Consistent with these indices, immunohistochemistry, Western blot and RT-PCR analysis indicated that NF-kappaB expression was significantly decreased in high dose group. Low dose of oxymatrine did not affect NF-kappaB expression in pMCAO rats.
    Oxymatrine reduced infarct volume induced by pMCAO, this effect may be through the decreasing of NF-kappaB expression.
    Chinese Journal of Digestion, 2003, 11(31):4912-5.
    Study on the anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium induced colitis of rats[Reference: WebLink]

    To investigate the anti inflammatory mechanism of Oxymatrine(OM)in dextran sulfate sodium(DSS) induced colitis of rats. Results Compared with DSS control group, the inflammatory symptoms and histological damages of colonic mucosa in OM treated group were significantly improved( P 0.02, P 0.05), the serum levels of TNF α, IL 6 and the expression of NF κB, ICAM 1 in colonic mucosa were significantly reduced( P 0.01, P 0.05, P 0.05, P 0.01).
    The fact that OM can reduce the serum level of TNF α, IL 6 and the expression of NF κB and ICAM 1 in colonic mucosa in DSS induced colitis of rats indicates that OM may ameliorates the colonic inflammation and thus alleriate diarrhea and bloody stool.
    Acta Pharmacol. Sin., 2014, 35(3):331-8.
    Oxymatrine attenuates diabetes-associated cognitive deficits in rats.[Pubmed: 24442148]
    Oxymatrine (OMT) is the major quinolizidine alkaloid extracted from the root of Sophora flavescens Ait (the Chinese herb Kushen) and exhibits diverse pharmacological actions.
    In this work we investigated the effects of OMT on diabetes-associated cognitive decline (DACD) in a rat model of diabetes and explored the mechanisms of action. The diabetic rats exhibited markedly reduced body weight and increased plasma glucose level. The memory function of the rats assessed using Morris water maze test showed significant reduction in the percentage of time spent in the target quadrant and the number of times crossing the platform, coupled with markedly prolongation of escape latency and mean path length. Moreover, the rats showed oxidative stress (significantly increased MDA, decreased SOD and reduced GSH levels), as well as significant increases of NF-κB p65 unit, TNF-α, IL-1β and caspase-3 levels in the cerebral cortex and hippocampus. Chronic treatment with OMT dose-dependently reversed these behavioral, biochemical and molecular changes in the diabetic rats. However, the swimming speed had no significant difference among the control, diabetic and OMT-treated diabetic rats.
    Chronic treatment with OMT alleviates diabetes-associated cognitive decline in rats, which is associated with oxidative stress, inflammation and apoptotic cascades.
    Int J Biol Macromol. 2010 May 1;46(4):425-8.
    Astragalus polysaccharide and oxymatrine can synergistically improve the immune efficacy of Newcastle disease vaccine in chicken.[Pubmed: 20149818]

    Three hundred and sixty 14-day-old chickens were divided into seven groups. The chickens, except for blank control group, were vaccinated with Newcastle disease vaccine, repeated at 28 days old. At the same time of the first vaccination, the chickens in three astragalus polysaccharide-oxymatrine (AP-OM) groups were orally administrated respectively with the mixture of AP-OM at high, medium and low concentrations, in astragalus polysaccharide (AP) group and oxymatrine (OM) group, with corresponding medicine, in non-medicine (NM) control group, with equal volume of physiological saline, once a day for 3 successive days. On 14, 21, 28, 35 and 42 days after the first vaccination, the changes of peripheral lymphocyte proliferation and serum antibody titers of the chickens were determined by MTT method and hemagglutination inhibition test. On 14, 28 and 42 days after the first vaccination, the serum IL-2 concentration was determined by Enzyme-linked Immunosorbent Assay (ELISA). The results showed that at most time points, the lymphocyte proliferation, antibody titers and IL-2 concentrations of 5 medicine-administrating groups were significantly higher than that of corresponding NM group. At some time points, the lymphocyte proliferation, antibody titers and IL-2 concentrations in high and medium doses of AP-OM groups were significantly or numberly higher than those in AP group and OM group.
    It indicated that AP-OM could significantly improve the immune efficacy of Newcastle disease vaccine, astragalus polysaccharide and oxymatrine possessed synergistical immunoenhancement.
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 3.7821 mL 18.9107 mL 37.8215 mL 75.643 mL 94.5537 mL
    5 mM 0.7564 mL 3.7821 mL 7.5643 mL 15.1286 mL 18.9107 mL
    10 mM 0.3782 mL 1.8911 mL 3.7821 mL 7.5643 mL 9.4554 mL
    50 mM 0.0756 mL 0.3782 mL 0.7564 mL 1.5129 mL 1.8911 mL
    100 mM 0.0378 mL 0.1891 mL 0.3782 mL 0.7564 mL 0.9455 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    槐定碱; Allomatrine CFN90222 641-39-4 C15H24N2O = 248.36 20mg QQ客服:215959384
    槐定碱; Sophoridine CFN97172 6882-68-4 C15H24N2O = 248.4 20mg QQ客服:215959384
    氧化槐定碱; Oxysophoridine CFN90290 54809-74-4 C15H24N2O2 = 264.36 5mg QQ客服:2159513211
    氧化槐果碱; Oxysophocarpine CFN98321 26904-64-3 C15H22N2O2 = 262.4 20mg QQ客服:1413575084
    苦参碱; Matrine CFN98835 519-02-8 C15H24N2O = 248.4 20mg QQ客服:1148253675
    12,13-去氢苦参碱; Lemannine CFN92839 58480-54-9 C15H22N2O = 246.4 5mg QQ客服:2159513211
    新槐胺; Neosophoramine CFN98875 52932-74-8 C15H20N2O = 244.3 5mg QQ客服:1148253675
    槐果碱; Sophocarpine CFN99182 145572-44-7 C15H22N2O = 246.35 20mg QQ客服:1148253675
    氧化苦参碱; 苦参素; Oxymatrine CFN99805 16837-52-8 C15H24N2O2 = 264.4 20mg QQ客服:3257982914
    槐苦参醇,槐醇; (+)-Sophoranol CFN92840 3411-37-8 C15H24N2O2 = 264.4 5mg QQ客服:215959384





    在线QQ: 215959384


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产